Status | Study |
RECRUITING |
Study Name: Extracellular Vesicles for HD Condition: Huntington Disease Date: 2023-10-08 |
RECRUITING |
Study Name: Benchmarking Integrated Care for People Living With Huntington's Disease in England Condition: Huntington Disease Date: 2023-04-12 Interventions: Survey only to gather people's experiences, opinions and needs. |
RECRUITING |
Study Name: Prospective Single-Timepoint Huntington's Disease Biospecimen Collection Study Condition: Huntington Disease Date: 2023-03-06 Interventions: Cohort 1-Huntington's Disease:The target blood volume of each phlebotomy visit will be 20 mL.The minimum accepted volume (in the |
RECRUITING |
Study Name: Prospective Single-Timepoint Huntington's Disease Biospecimen Collection Study Condition: Huntington Disease Date: 2023-03-06 Interventions: Cohort 1-Huntington's Disease:The target blood volume of each phlebotomy visit will be 20 mL.The minimum accepted volume (in the |
RECRUITING |
Study Name: GENERATION HD2. A Study to Evaluate the Safety, Biomarkers, and Efficacy of Tominersen Compared With Placebo in Participants With Prodromal and Early Manifest Huntington's Disease. Condition: Huntington Disease Date: 2022-12-16 Interventions: 60 mg tominersen administered intrathecally every 16 weeks |
COMPLETED |
Study Name: Characterization and Quantification of Motor Speech Disorders in Huntington's Disease: Identification of Acoustic Markers Condition: Huntington Disease Date: 2020-11-01 Interventions: A first speech evaluation with the clinical evaluation of dysarthria during 30 minutes is proposed to exclude very severe dysarthria. |
Completed |
Study Name: Working Memory Training in Huntington's Disease Condition: Huntington's Disease Date: 2016-09-30 Interventions: Behavioral: Cogmed QM The intervention consisted of 25 Cogmed sessions, typically completed over a five |
Not yet recruiting |
Study Name: Safety Evaluation of Cellavita HD Administered Intravenously in Participants With Huntington's Disease Condition: Huntington Disease Date: 2016-03-11 Interventions: Other: Cellavita HD lower dose |
Recruiting |
Study Name: Deep Brain Stimulation (DBS) of the Globus Pallidus (GP) in Huntington's Disease (HD) Condition: Huntington Disease Date: 2015-08-27 Interventions: Device: ACTIVA® PC neurostimulator (Model 37601) the stimulator in the stimulation group will be tu |
Recruiting |
Study Name: Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of IONIS-HTTRx in Patients With Early Manifest Huntington's Disease Condition: Huntington's Disease Date: 2015-08-01 Interventions: Drug: IONIS HTTRx Other Name: |